Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $37.00. They now have a "buy" rating on the stock.
Beta Bionics (NASDAQ:BBNX) was given a new $28.00 price target on by analysts at Robert W. Baird.
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
Beta Bionics (NASDAQ:BBNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Beta Bionics Announces Participation at Upcoming Investor Conferences